103

News

Biotech giant Bavarian Nordic sees share price spike on the back of HPV vaccine deal

TheCopenhagenPost
December 18th, 2015


This article is more than 9 years old.

The Danish company will receive 171 million dollars from Johnson and Johnson subsidiary

The research is paying off for Bavarian Nordic (photo: Bavarian Nordic)

The share price of the Danish biotech company Bavarian Nordic has shot up by 6 percent following the announcement that the company has signed a licence and collaboration deal worth 171 million dollars with Janssen Pharmaceuticals, a division of Johnson and Johnson.

The deal will give Janssen exclusive rights to Bavarian Nordic’s MVA-BN vaccine in the treatment of human papillomavirus (HPV). The product will be combined with Janssen’s AdVac technology in the treatment of all cancers induced by HPV.

CEO: Potential to transform treatment paradigm
Paul Chaplin, the head of Bavarian Nordic, sees great potential in the collaboration.

“We are excited to expand our collaboration with Janssen on the evaluation of MVA-BN as a therapeutic approach to HPV, which represents a significant opportunity to transform the treatment paradigm in cervical and other cancers induced by the virus,“ he said.

“Through the ongoing collaboration on Ebola, we have already made significant advances with our MVA-BN technology, demonstrating its potential to enhance and prolong immune responses induced by Janssen’s AdVac technology, and we look forward to expanding the partnership to explore the same concept for HPV.”

Bavarian Nordic has had an exceptional year, with its share price increasing by more than 70 percent since January.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”